Cancer Chemotherapy II

  • K. Hellmann
  • T. A. Connors

Part of the Chemotherapy book series (CT, volume 8)

Table of contents

  1. Front Matter
    Pages i-xviii
  2. L. S. Evseenko, S. W. Gorkova, E. A. Minenkova, M. M. Fomina, G. G. Poroshenko
    Pages 1-3
  3. J. de Ruiter, T. Smink, J. Jansen, L. M. van Putten
    Pages 9-10
  4. G. F. Rowland, G. J. O’Neill, D. A. L. Davies
    Pages 11-16
  5. I. Barasoain, A. Portoles, J. M. Rojo, C. Sunkel
    Pages 21-26
  6. E. Tsubura, K. Yata, G. Hisano, K. Tominaga, H. Sasaki, S. Sone
    Pages 27-30
  7. K. Lapis, A. Jeney, L. Kopper, B. Szende, J. Takacs
    Pages 37-42
  8. H. Fujita, M. Sugiyama, K. Kimura
    Pages 51-57
  9. Michiaki Kawano, Katsuhito Kohzai, Osamu Saitoh, Eiro Tsubura
    Pages 59-62
  10. A. De Barbieri
    Pages 87-89
  11. V. C. Barry, J. G. Belton, M. L. Conalty
    Pages 97-101
  12. V. C. Barry, M. L. Conalty, J. F. O’Sullivan, D. Twomey
    Pages 103-106

About this book


The International Society of Chemotherapy meets every two years to review progress in chemotherapy of infections and of malignant disease. Each meeting gets larger to encompass the extension of chemotherapy into new areas. In some instances, exp~sion has been rapid, for example in cephalosporins, pen­ icillins and combination chemotherapy of cancer - in others slow, as in the field of parasitology. New problems of resistance and untoward effects arise; reduction of host toxicity without loss of antitumour activity by new substances occupies wide attention. The improved results with cancer chemotherapy, es­ pecially in leukaemias, are leading to a greater prevalence of severe infection in patients so treated, pharmacokinetics of drugs in normal and diseased subjects is rece1v1ng increasing attention along with related problems of bioavailability and interactions between drugs. Meanwhile the attack on some of the major bacterial infections, such as gonorrhoea and tubercu­ losis, which were among the first infections to feel the impact of chemotherapy, still continue to be major world problems and are now under attack with new agents and new methods. From this wide field and the 1,000 papers read at the Congress we have produced Proceedings which reflect the variety and vigour of research in this important field of medicine. It was not possible to include all of the papers presented at the Congress but we have attempted to include most aspects of cur­ rent progress in chemotherapy.


cancer chemotherapy kinetics pharmacokinetics research resistance toxicity

Editors and affiliations

  • K. Hellmann
    • 1
  • T. A. Connors
    • 2
  1. 1.Westminster Hospital and Imperial Cancer Research FundUK
  2. 2.Chester Beatty Research InstituteUK

Bibliographic information

  • DOI
  • Copyright Information Plenum Press, New York 1976
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-4354-7
  • Online ISBN 978-1-4613-4352-3
  • About this book